|
|
|
|
|
1
|
United States Type 2 Diabetes Market |
Nov 2009 |
$7,500.00 |
|
Intellent's new industry report focuses on the US type 2 diabetes market. This report provides valuable insight and access to the competitive information and analysis necessary to make decisions regarding the direction of the market
more...
Published by: Intellent
| Search inside this report |
|
|
2
|
Company Financials: Bayer AG |
Nov 2009 |
$75.00 |
|
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
more...
Published by: Datamonitor
|
|
|
3
|
Thailand Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity
more...
Published by: Business Monitor International
| Search inside this report |
|
|
4
|
Argentina Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. BMI’s updated forecasts see themarket reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of12.68% in US dollar terms. With
more...
Published by: Business Monitor International
| Search inside this report |
|
|
5
|
Takeda Pipeline, Products, Performance, Potential |
Nov 2009 |
$1,130.00 |
|
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
more...
Published by: Espicom Healthcare Intelligence
| Search inside this report |
|
|
6
|
Poland Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is adestination for almost all multinationals operating within the region. Poland’s pharmaceutical market hasshown consistently strong growth
more...
Published by: Business Monitor International
| Search inside this report |
|
|
7
|
Merck & Co. Performance, Products, Pipeline and Potential |
Nov 2009 |
$1,130.00 |
|
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
more...
Published by: Espicom Healthcare Intelligence
| Search inside this report |
|
|
8
|
Australia Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated at US$352 in2008. While not particularly high by Western
more...
Published by: Business Monitor International
| Search inside this report |
|
|
9
|
Nigeria Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
The value of Nigeria’s pharmaceutical market in 2008 was NGN80.9bn (US$680mn). We forecast a12.8% year-on-year (y-o-y) growth in local currency during 2009, expecting that the market will grow bya compound annual growth rate (CAGR) of
more...
Published by: Business Monitor International
| Search inside this report |
|
|
10
|
Kenya Pharmaceuticals and Healthcare Report Q1 2010 |
Nov 2009 |
$495.00 |
|
BMI’s proprietary Drug Expenditure Forecast Model reveals that the Kenyan pharmaceutical market willreturn to a double-digit growth rate in 2009 (in local currency terms), after declining to single-digitgrowth the previous year. During 2008, OTC and
more...
Published by: Business Monitor International
| Search inside this report |
|
|
11
|
Les Laboratoires Servier: PharmaVitae Profile |
Nov 2009 |
$5,700.00 |
|
Introduction This analysis examines the historical and forecast performance for Servier in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts
more...
Published by: Datamonitor
|
|
|
12
|
King Pharmaceuticals Inc.: PharmaVitae Profile |
Nov 2009 |
$5,700.00 |
|
Introduction This analysis examines the historical and forecast performance for King in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts
more...
Published by: Datamonitor
|
|
|
13
|
Top 100 Pharmaceutical Manufacturers Industry Analysis |
Nov 2009 |
$1,500.00 |
|
The Global Top 100 Pharmaceutical Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
14
|
Top 50 Pharmaceutical Companies Report |
Nov 2009 |
$1,300.00 |
|
The Global Top 50 Pharmaceutical Companies Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
15
|
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies |
Nov 2009 |
$25,800.00 |
|
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces
more...
Published by: Venture Planning Group
|
|
|
16
|
UAE Healthcare Sector Forecast to 2012 |
Nov 2009 |
$1,000.00 |
|
The UAE has emerged as one the fastest growing healthcare markets in the Middle East. The country’s healthcare sector has grown at double digit rate to keep pace with incessantly rising demand for quality treatment
more...
Published by: RNCOS
|
|
|
17
|
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis |
Nov 2009 |
$175.00 |
|
Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions.
more...
Published by: Aruvian's R'search
| Search inside this report |
|
|
18
|
Chr Hansen - SWOT Framework Analysis |
Nov 2009 |
$95.00 |
|
SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or
more...
Published by: Aruvian's R'search
| Search inside this report |
|
|
19
|
Biopharmaceuticals Industry Report |
Nov 2009 |
$1,500.00 |
|
The Global Biopharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
20
|
Generic Pharmaceuticals Industry Report |
Nov 2009 |
$1,500.00 |
|
The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
21
|
Romania - Health Care Report |
Nov 2009 |
$250.00 |
|
Romania - Health Care Report offers a comprehensive review of the current state of the Romanian health care system, the pharmaceutical industry and the medical equipment market. It provides a business perspective on private and
more...
Published by: TrendsSpotting.com
| Search inside this report |
|
|
22
|
Pharmaceutical Industry in Mexico |
Nov 2009 |
$275.00 |
|
Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease.
Mexico’s pharmaceutical policy environment is in a period of
more...
Published by: Aruvian's R'search
| Search inside this report |
|
|
23
|
BI for Drug Development: Oracle Introduces Clinical Development Analytics |
Nov 2009 |
$1,500.00 |
|
This IDC Health Insights Perspective highlights the announcement of a dedicated life science business intelligence (BI) solution introduced recently at Oracle OpenWorld 2009 that promises to deliver actionable insights into clinical development processes. Oracle Clinical
more...
Published by: IDC
| Search inside this report |
|
|
24
|
Pharmaceutical Manufacturers Report - Chinese |
Nov 2009 |
$1,500.00 |
|
The Chinese Pharmaceutical Manufacturers Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
25
|
Asia Pacific Pharma Sector Analysis |
Nov 2009 |
$1,200.00 |
|
The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region
more...
Published by: RNCOS
|
|
|
|
|
|
0 items
